Factors
Stocks
Valuation
Portfolio
Visualizations
More
Research date: June 13, 2026
Closing price before research date: $85.66
Current price: $91.98

Shell plc (NYSE: SHEL) — The Disciplined Supermajor You Buy for the Cash, Not the Re-Rating

Sector: Energy — Integrated Oil & Gas (GICS Integrated Oil & Gas) Report date: 2026-06-13 | Price (ref): ~$85.66/ADR (NYSE close, 2026-06-12) | Market cap: ~$237B | EV: ~$295B ADR structure: 1 ADR = 2 ordinary shares | ADSs: ~2.83B (~5.69B ordinary shares) | Dividend: ~$2.89/ADR trailing (~3.4%; ~3.6% fwd) | CIK: 0001306965 | FY-end: December | Filer: Foreign private issuer (20-F / 6-K, IFRS, USD)

Primary sources: SEC EDGAR (Form 20-F FY2025 filed 2026-03-12, FY2024/FY2023 20-Fs, the 6-K corpus); Shell’s Capital Markets Day (2025-03-25), Q1-2026 (2026-05-07) and Q4-2025 (2026-02-05) earnings calls and the ARC Resources M&A call (2026-04-28); UK RNS / PDMR notifications; company filings, earnings-call transcripts, and public market data.


⚡ Claude’s Take

This block is the author’s own independent opinion and general information only. It is not investment advice and not a recommendation to buy or sell any security. The analysis that follows takes no position and sets no price target; this opening block is the single, clearly-labeled exception where a directional view is expressed.

Verdict: BUY / accumulate with discipline — the best cash-flow value among the integrated supermajors, but you are buying the per-share compounding machine and the ~9% shareholder yield, NOT a second leg of multiple re-rating. Directional accumulation zone ~$75–88 (≈5–6× mid-cycle EV/EBITDA, ≈9–10% normalized FCF yield, ≈1.3–1.4× book); back up the truck only on a crude-driven flush into the $60s. Conviction: medium.

Tag: “The re-rating’s done; the compounding isn’t.” Shell is the rare supermajor that screens cheap on cash and rich on book at the same time — and both halves of that sentence are the thesis. Cross-sectionally it trades at ~6× EV/EBITDA and ~9× forward earnings, a ~45% EV/EBITDA discount to ExxonMobil and Chevron (~11–12×) and right alongside European peer TotalEnergies, while paying out a ~9% combined shareholder yield (≈3.4% dividend + ≈5–6% buyback). Wael Sawan’s “value over volume” reset — capex cut to $20–22B, $5.1B of structural cost out, distributions raised to 40–50% of CFFO, ~$65B of buybacks retiring ~12.5% of the share count in two years, and an explicit >10% FCF-per-share CAGR target to 2030 — is real, well-executed, and is the cleanest per-share story in the sector. That is what I am paying for. What I am not paying up for is more multiple: on its own ten-year history Shell sits at the 97.9th percentile of P/B (1.42×) and 98.0th of P/S even as ROACE has fallen to a cycle-low 9.4%. The discount-closing trade toward US-major parity has largely happened; from here the book multiple is the vulnerable axis. Unlike XOM and CVX, though, Shell is not also at a peak P/E (66th percentile) — so the “peak multiple at trough returns” trap is only half-present, which is precisely why the risk/reward is more symmetric and I land a notch more constructive than the HOLD I’d give the US majors.

What the market is pricing correctly: Shell’s #1 global LNG franchise (~17% of seaborne trade, ~44 Mtpa equity), the genuineness of the cost-and-capital discipline, and the durability of the Marketing annuity. What it may be mispricing: that ~$89–95 Brent is a Strait-of-Hormuz war premium (April-2026 monthly average $117, the highest since 2008), not a structural price — normalized earnings sit below the spot optic; that FY2025 organic reserve replacement was negative (~−40%), so the upstream leans on M&A (ARC Resources) to stand still; and that the 2025–2030 global LNG supply wave (Qatar, US Gulf) is bearing down on the trading/optimization margins that flatter Integrated Gas — Shell’s largest and least-recurring earnings layer. The framing is deep-value-cyclical-with-a-best-in-class-capital-allocator, not quality-compounder: you are not getting a moat, you are getting a disciplined, low-cost-of-capital operator returning a double-digit yield while it shrinks the share count, at a cash-flow multiple cheaper than its US peers. What flips me firmly bullish: hard proof ROACE clears >10% at a normalized $70 Brent (not war prices) while LNG margins hold and the buyback stays in the 40–50% band — i.e., the per-share machine compounding on rising, not trough, earnings. What flips me bearish: Brent reverting to the $50s–60s with the buyback cut below the band to defend the balance sheet, and the 98th-percentile P/B reverting toward Shell’s historical sub-1.2× Europe discount — a multiple unwind, not an earnings miss, is the principal downside. Don’t chase it on a war-premium spike; accumulate the cash-flow yield on weakness.


1. Executive Summary

Shell plc is one of a handful of Western integrated oil-and-gas supermajors — a ~$237B-market-cap, London-headquartered energy company spanning liquefied natural gas, upstream oil and gas, fuels and lubricants marketing, chemicals and refining, and a small renewables/trading arm. In FY2025 it generated $266.9B of revenue, $18.5B of Adjusted Earnings, $42.9B of cash flow from operations, and returned $22.4B to shareholders (dividends plus buybacks). It is, by its own disclosure and corroborated by third-party data, the world’s largest publicly-listed supplier of LNG (~17% of global LNG trade; ~44 Mtpa of equity capacity), and it carries a strong investment-grade balance sheet (net debt $45.7B, gearing ~21%, of which ~$29B is leases).

The central tension. Shell is a high-quality operator and capital-allocator inside a structurally unattractive industry, and the stock now reflects much of that improvement. Three facts frame the entire memo. First, earnings are at a cyclical trough: Adjusted Earnings fell from a $39.9B all-time record (FY2022) to $28.3B (FY2023), $23.7B (FY2024) and $18.5B (FY2025), and ROACE compressed from 15.8% to 9.4% — a function of lower realized oil/LNG prices, weaker trading margins and a collapsed chemicals cycle, not management error. Second, the stock has re-rated: on its own ten-year history Shell trades at the 97.9th percentile of price-to-book (1.42×) and the 98.0th of price-to-sales (0.97×), though only the 66th percentile of P/E (14.5× trailing) — a balance-sheet/revenue re-rating that capitalizes Sawan’s discipline and the narrowing of Shell’s chronic discount to the US majors. Third, it is nonetheless cheap cross-sectionally: ~6× EV/EBITDA and ~9× forward P/E versus ~11–12× and ~14× for ExxonMobil and Chevron — the persistent “Europe/IOC discount” is intact even after the re-rate.

The bull and bear in one paragraph. The bull owns the per-share machine and the LNG franchise: ~$65B of buybacks over four years (−12.5% shares in two), a 40–50%-of-CFFO distribution policy management calls “sacrosanct,” a >10% FCF/share CAGR target to 2030, the #1 global LNG position riding a multi-decade demand super-cycle, and a stable Marketing annuity (~$4B of Adjusted Earnings, rising through the down-cycle) the market under-credits. The bear notes that the same assets earned more than twice as much in 2022 as in 2025 — returns are set by the oil price, not by Shell — that you are paying a near-record book multiple for record-low returns, that FY2025 organic reserve replacement was negative (~−40%, three-year average ~55%), that the LNG supply wave threatens the trading margins flattering its largest segment, and that the ~$89–95 Brent underpinning the cheap-looking forward multiple is a Strait-of-Hormuz war premium destined to normalize lower.

Moat verdict. Shell has no franchise moat. It is a commodity price-taker; its three-year earnings collapse on an unchanged asset base is the definitional disproof. What it has is (a) a durable, broad supply/cost advantage (Greenwald’s supply-side type) shared with the other majors — scale, integration, low-cost legacy positions — and (b) a genuine but volatile scale-plus-intangible edge in LNG and global trading that is the strongest, and least appreciated, part of the franchise but is not an earnings stabilizer (it amplifies results in both directions). Best characterized: the best-positioned gas/LNG-and-trading-tilted supermajor, run by the most disciplined capital allocator in the peer group, priced at the top of its own history for a commodity business at trough returns — but cheaper on cash flow than its US peers, with the strongest per-share-compounding engine in the sector providing a downside cushion they lack.

No recommendation and no price target appear below this summary; the body discusses valuation only as embedded expectations and scenarios.


2. Business Overview

Shell plc (founded 1897; renamed from Royal Dutch Shell plc in January 2022; headquartered in London; ~84,000 employees) is a vertically integrated energy and petrochemical company. It reports through five operating segments plus Corporate, and the earnings composition is the single most important structural fact about the business.

FY2025 Segment Adjusted Earnings (the basis management runs the company on; $M, incl. non-controlling interest, Note 7):

Segment FY2023 FY2024 FY2025 Character
Integrated Gas (LNG) 13,919 11,390 8,024 Largest engine (~43%); LNG + trading; most volatile, price- & margin-lagged
Upstream 9,806 8,395 7,442 Oil & gas E&P; pure commodity price-taker
Marketing 3,312 3,885 3,994 The quality stream — fuels retail, lubricants, B2B; rising counter-cyclically
Chemicals & Products 3,616 2,934 1,051 Refining + petrochemicals; deep trough, chemicals sub-segment loss-making
Renewables & Energy Solutions 756 (497) 172 Barely breakeven; positive only because power trading offsets renewables losses
Corporate (2,875) (1,968) (1,870) Net interest / tax / FX drag
Total (incl. NCI) 28,534 24,139 18,813

(FACT: Shell FY2025 20-F, Note 7. Segments were re-presented effective 1-Jan-2025, so per-segment Adjusted Earnings is comparable FY2023–FY2025 only; pre-2023 per-segment splits use the prior basis.)

The composition tells the story: Integrated Gas + Upstream ≈ 83% of segment Adjusted Earnings — i.e., the great majority of profit is directly geared to the price of LNG, crude oil and natural gas. Two layers are different in kind. Marketing (~$4.0B, ~21% of segment AE) is the one genuinely high-quality, stable, counter-cyclically rising stream — mobility (a global retail fuel network including EV charging and convenience), lubricants (the #1 global lubricants brand by volume), and commercial B2B fuels — with brand- and convenience-supported margins that look more like a consumer-retail/specialty business than a commodity one. And Renewables & Energy Solutions is, on the evidence, a mirage as a clean-energy growth story: its small positive Adjusted Earnings came entirely from power and pipeline-gas trading, offset by losses in renewable generation, hydrogen and carbon capture. Shell’s “renewables” segment does not, today, make money from renewables.

What the company actually does — the value chain. Integrated Gas finds and produces natural gas, liquefies it (or converts it to GTL products), and — critically — trades and optimizes a vast physical LNG portfolio: Shell liquefied 28.4 Mt in 2025 and sold a record 72.9 Mt of LNG (+11% YoY), sourcing third-party volumes (boosted by the Pavilion Energy acquisition closed March 2025 and the first cargoes from LNG Canada, in which Shell holds 40%, in mid-2025). Upstream explores for, develops and lifts crude oil, natural gas and NGLs, selling into global markets at Brent/Henry-Hub-linked prices; profitability is realized price minus lifting/finding/development cost. Marketing buys and brands refined products and lubricants and sells them through a global retail and B2B network — the layer with actual customer relationships and pricing power. Chemicals & Products refines crude into fuels and feedstocks (earning the crack spread) and converts hydrocarbons into olefins/polyolefins (earning the chemicals spread, currently deeply compressed). Renewables & Energy Solutions houses power generation/trading, hydrogen, biofuels and CCS.

Production and reserves. FY2025 production was 2,800 kboe/d (2024: 2,836; 2023: 2,791) — flat-to-declining, roughly 54% liquids / 46% gas. Proved reserves were 8,123 Mboe at year-end 2025, down 427 Mboe before the year’s production — i.e., negative organic reserve replacement (~−40%) in 2025 (three-year average ~55%) — implying a reserve life of ~8 years and a portfolio that, absent reinvestment or acquisition (see ARC Resources, below), is gradually liquidating. This is a recurring tension for the whole sector and a specific watch-item for Shell.

Revenue character. FY2025 revenue was $266.9B, down from the $381.3B FY2022 peak — structurally cyclical, with only a thin recurring layer (Marketing, parts of Integrated Gas infrastructure). Roughly four-fifths of segment profit is commodity-price-driven; the recurring/annuity component is the Marketing franchise and the contracted/infrastructure portion of LNG.

Verdict (Business Overview): A gas/LNG-and-trading-tilted supermajor with one genuinely high-quality stream (Marketing) and one scarce, world-leading franchise (LNG), wrapped around a large, cyclical, price-taking upstream and a trough-bound chemicals book. The earnings base is ~83% commodity-geared; the recurring layer is real but minority.


3. Industry Dynamics

Structure. Integrated oil & gas is a global, capital-intensive, commodity industry of a handful of Western supermajors (ExxonMobil, Chevron, Shell, TotalEnergies, BP), the international and national oil companies (Saudi Aramco, ADNOC, PetroChina, Petrobras, Equinor), and large independents (ConocoPhillips, EOG, Canadian Natural). No participant sets the price of its primary product; crude is priced off Brent/WTI in a market materially influenced by OPEC+ supply decisions, and LNG off oil-indexed and hub-linked contracts plus a volatile spot market. The product is undifferentiated; profitability is realized price minus cost. This is the cardinal fact: the industry has no pricing power, returns are dictated by exogenous commodity prices, and the asset base depletes and must be perpetually replaced at rising marginal cost.

Profit pools and the oil backdrop. Mid-2026 Brent is ~$89–95/bbl, and the April-2026 monthly average reached $117.29 — the highest since June 2008 — during peak disruption around the Strait of Hormuz (through which ~20% of seaborne crude flows). This is a geopolitical war premium, not a structural repricing: the EIA’s forward strip reverts toward the low-$60s/$70s over the medium term, and a de-escalation (a US–Iran understanding was being signaled in June 2026) would deflate it quickly. Any analysis that capitalizes ~$90 oil into Shell’s normalized earnings is mis-specified — this memo normalizes toward a ~$70 mid-cycle Brent (with bear/bull cases at ~$60 and ~$85+). Notably, Shell’s core Middle East position (Oman, ~10% of global volumes does not transit Hormuz) means the disruption is more a price tailwind than an operational threat for Shell specifically.

LNG sub-market. Global LNG trade reached ~407 Mt in 2024 but grew only ~2 Mt year-on-year — the slowest in a decade — reflecting a mid-decade supply pause before a large 2025–2030 capacity wave (Qatar’s North Field expansions, multiple US Gulf trains). Demand is projected to grow materially to 2040 (Shell’s own outlook cites +~60%, driven by Asia and, increasingly, AI/data-center power), which underpins the strategic case for Shell’s LNG tilt. But the same supply wave is a double-edged sword: incoming liquefaction capacity can compress spot LNG spreads and the trading/optimization margins that flatter Integrated Gas later this decade, even as Shell’s volumes grow.

Capital-cycle read (Marathon lens). The integrated-oil industry sits at a comparatively favorable point in the capital cycle for disciplined incumbents. Post-2020 capital discipline plus heavy consolidation (XOM–Pioneer, CVX–Hess, ConocoPhillips–Marathon, and the WSJ-reported June-2025 Shell/BP takeover speculation that Shell formally denied) means supply-side capital is being withdrawn and rationalized from upstream — exactly the supply-side contraction that historically precedes better returns for the survivors. The clear exception, and the caution flag, is LNG, the one sub-sector where capital is still entering aggressively (the 2025–2030 wave); per Marathon, capital pouring into a high-return niche is the classic setup for future margin mean-reversion. Regulation/transition policy is a slow structural overhang (carbon pricing, windfall-tax precedent in Europe, transition-demand uncertainty on oil), but the near-term policy direction has eased and Shell has retreated from its most aggressive decarbonization commitments.

Verdict (Industry): Structurally a bad industry — no pricing power, brutal capital intensity, perpetual depletion, secular-demand uncertainty — at a comparatively good cyclical/capital-cycle moment for disciplined, low-cost incumbents. LNG is the most attractive niche Shell occupies, but it carries its own incoming-supply risk that the bull case tends to understate.


4. Competitive Position

The moat question, answered directly: at the corporate level, Shell has no franchise moat. It is a commodity price-taker, and the decisive disconfirming test is its own recent record — the same asset base produced Adjusted Earnings of $28.3B (2023) → $23.7B (2024) → $18.5B (2025), a 34% decline driven by falling prices and trading swings, not by any deterioration management caused or could have prevented. Earnings that halve when the commodity price falls, on an unchanged franchise, is the definitional signature of no pricing power and no franchise moat. A “moat” that cannot be tied to a financial outcome that would deteriorate without it is not a moat — and here the financial outcome deteriorates regardless.

What Shell genuinely does have are two real but bounded advantages:

1. A broad supply/cost advantage (Greenwald supply-side type), shared with the other majors. Scale, vertical integration, low-cost legacy positions, project-execution capability and a low cost of capital let Shell earn acceptable returns at prices that would bankrupt marginal producers, and survive the trough. This is real and worth a premium to weaker operators — but it is cost-parity within an oligopoly, not individual dominance. It does not protect returns when the oil price falls; it only protects relative survival.

2. A genuine but volatile scale-plus-intangible edge in LNG and global trading — the strongest, and most under-appreciated, part of the franchise. Shell is the #1 listed LNG supplier (~44 Mtpa equity capacity, ~17% of global LNG trade, “servicing nearly a fifth of global LNG demand” per the 20-F), operates one of the world’s largest LNG shipping fleets (~10% of the market), trades >8M bbl/d of crude, and holds leading positions in low-carbon fuels (~20% of North America/Europe SAF). Management (CMD 2025) describes this trading scale and physical-network footprint as “developed over decades… hard to replicate,” and the claim is defensible: the combination of physical assets, market positions and informational reach creates an optionality/informational edge that neither pure-play E&Ps nor standalone trading houses can easily replicate. This is the one place the market-share-stability test actually supports a durable edge — Shell has held #1 in LNG for years.

The critical caveats on the trading edge. First, it is volatile, not stabilizing — trading P&L is partly a function of price volatility and was a major down-swing in 2024–25 (lower volatility → lower trading and optimization margins, the single biggest driver of the Integrated Gas and RES earnings declines). It amplifies earnings in both directions; it is not an annuity. Second, it is deliberately opaque — Shell does not disclose trading P&L granularly, which both protects the edge and prevents investors from underwriting its durability. Third, the 2025–2030 LNG supply wave is a direct structural threat to the optimization spreads that fatten it.

ROIC and peer cross-check. ROACE of 9.4% in 2025 (vs 11.3% in 2024, 12.8% in 2023) is cycle-low and not moat-like — a true franchise shows persistently high, stable returns on capital; Shell’s swing with the commodity. On a cross-sectional basis at the 2025 trough, Shell (~9.4%) sits roughly in line with ExxonMobil (~9–10%) and above Chevron (~6.6%, depressed by the Hess deal). Versus peers on portfolio quality: ExxonMobil owns the lowest-cost barrels in the group (Guyana ~$25–35/bbl, Permian <$35/bbl) and targets ~17% corporate ROCE by 2030; Chevron has similarly advantaged barrels (Guyana via Hess, Permian, Tengiz). Shell’s upstream is solid but is not the lowest-cost barrel set — its differentiation is the gas/LNG-and-trading tilt and a larger, higher-quality Marketing franchise, a more midstream/trading-shaped major than XOM/CVX’s pure low-cost-barrel play. TotalEnergies is the closest structural analogue; BP is the weaker sibling (and the 2025 takeover-target narrative).

Verdict (Competitive Position): A durable cost advantage (oligopoly cost-parity) plus a genuine-but-volatile LNG/trading scale-and-intangible edge — not a franchise moat and not return stability. Shell is the best-positioned gas/LNG/trading-tilted supermajor and arguably the best capital allocator in the group, but it is fundamentally a price-taker. The competitive case justifies a premium to weaker operators and supports the narrowing of its discount to the US majors; it does not justify treating the business as a quality compounder.


5. Growth History and Forward Opportunities

History. Volume growth is not the Shell story and has not been for years: production has drifted from ~3,237 kboe/d (2021, pre-disposals) to ~2,800 kboe/d (2025) as the company high-graded the portfolio and divested lower-return positions. Revenue and earnings have been entirely cycle-driven — the 2022 commodity spike produced an all-time record, and the subsequent three years normalized down. The genuine “growth” since 2023 has been in per-share value (via buybacks) and in LNG volumes (record 72.9 Mt sold in 2025, +11%), not in corporate production or headline earnings.

Forward opportunities — quality is high, but the levers are per-share and LNG, not broad volume:

  • LNG volume growth, 4–5% sales CAGR to 2030. The clearest organic lever. LNG Canada Trains 1&2 began exporting in 2025 (40-yr licence; Shell 40%); the Pavilion acquisition added third-party portfolio volumes; further capacity (Qatar offtake, North America) builds toward the 2030 target. LNG is largely Brent-linked, so this is commodity-levered volume growth, not a fixed annuity — but it is genuine and rides a multi-decade demand tailwind.

  • Production CAGR lifted from ~1% to ~4% via ARC Resources. The ~$22B ARC acquisition (announced April 2026) adds ~390 kboe/d of Canadian Montney gas, feeds LNG Canada, extends reserve life and converts a roughly flat production profile into modest growth — the one large inorganic move, and a disciplined, FCF/share-accretive one (from 2027).

  • The >10% normalized FCF-per-share CAGR to 2030 target. This is the headline financial growth objective and the one now embedded as an executive-pay metric (2026 PSA). It is achievable without much volume growth — it rests on (a) the ~$5–7B structural cost-out, (b) accretive LNG, and crucially © the buyback retiring shares. Even on flat Adjusted Earnings, a sustained 3–4%/yr share-count reduction compounds per-ADR earnings — this is the real mechanism, and it is high-quality because it is value-, not volume-, driven.

  • Marketing as a durable growth/quality stream. Mobility (incl. EV charging and convenience retail), lubricants and B2B fuels — the ~$4B annuity that grew through the down-cycle — is the segment management explicitly flags as under-valued in a sum-of-the-parts (capable of a ~10–12× EBITDA retail multiple vs Shell’s ~3–4× blended).

Verdict (Growth): High-quality, per-share-value-led growth with a modest commodity-levered volume kicker — not a high-growth business. The thesis is FCF/share compounding plus LNG, not production growth. This is the right kind of growth for a price-taking, capital-intensive industry (Marathon would approve of returning capital and growing per-share value rather than chasing volume), but investors expecting top-line or production-led growth will be disappointed.


6. Financial Quality

Five-year financial summary ($M unless noted; reconciled to FY2025 and FY2023 20-Fs):

Metric FY2021 FY2022 FY2023 FY2024 FY2025
Revenue 261,504 381,314 316,620 284,312 266,886
Income attrib. to shareholders (IFRS) 20,101 42,309 19,359 16,094 17,837
Adjusted Earnings (preferred metric) 19,289 39,870 28,250 23,716 18,528
Adjusted EBITDA 55,004 84,289 68,538 65,803 56,135
CFFO 45,104 68,414 54,191 54,687 42,863
Cash capital expenditure 19,697 24,833 24,392 21,085 20,915
Free cash flow 40,343 45,965 36,457 39,533 26,052
Dividends paid 6,253 7,405 8,393 8,668 8,472
Buybacks (cash) 2,889 18,437 14,617 13,898 13,879
ROACE 8.5% 15.8% 12.8% 11.3% 9.4%
Net debt (Dec 31) 52,556 44,837 43,542 38,809 45,687
Gearing 23.1% 18.9% 18.8% 17.7% 20.7%
Total debt 89,086 83,795 81,541 77,078 75,643
Production (kboe/d) 3,237 2,864 2,791 2,836 2,800
Adj EPS ($/ordinary share) 2.49 5.43 4.20 3.76 3.15
Adj EPS ($/ADR = 2 ord shares) 4.98 10.86 8.40 7.52 6.30
DPS ($/ordinary share) 0.894 1.038 1.294 1.390 1.446
Wtd-avg basic shares (m, ordinary) n/a n/a 6,733.5 6,299.6 5,890.8

(FACT: Shell FY2025 20-F. FY2023 ROACE restated 11.6%→12.8% between filings.)

The cyclicality is the dominant feature. FY2022 was an all-time record (Adjusted Earnings $39.9B, IFRS net income $42.3B); FY2025 is a cyclical trough ($18.5B), driven by lower realized liquids and LNG prices, weaker trading/optimization margins, and a deeply depressed chemicals cycle. Margins, ROACE and FCF all move with the commodity, and FY2026 will be temporarily flattered by the Hormuz war premium — the through-cycle figure, not the FY2025 trough or an FY2026 spike, is the right anchor.

Quality of earnings — be skeptical of “Adjusted.” Three points matter:

  1. Adjusted Earnings sits above IFRS net income across the cycle, because “identified items” (the bridge) are large, lumpy and usually negative: net charges of −$8.2B (FY2023) and −$7.4B (FY2024), dominated by impairments, restructuring, currency-translation reclassifications and unfavorable commodity-derivative fair-value moves. In FY2025 identified items netted to only −$53M — but only because a ~$1.95B gain on the Shell UK offshore (Adura JV) disposal offset the impairments. The collapse of the FY2025 IFRS-vs-AE gap to ~$0.7B was flattered by a divestment gain, not by an absence of charges. In an asset-heavy business, impairments recur; Adjusted Earnings systematically understates the true economic depreciation of capital. We weight IFRS net income and FCF over Adjusted Earnings.

  2. CFFO is high but trading makes it volatile. CFFO ($42.9B FY2025) far exceeds net income, driven by ~$25.3B of DD&A (normal for a major), but it swings sharply on the trading book’s working-capital and derivative-margin movements. In Q1-2026, an ~$11B working-capital outflow (commodity prices inflating inventory/receivables/margining) drove CFFO and net debt sharply — management expects most to reverse. Single-quarter cash flow and net debt are noisy and should never be annualized.

  3. Net debt optics overstate financial leverage. Net debt of $45.7B (gearing 20.7%) includes ~$28.9B of lease liabilities; net debt ex-leases is only ~$16.8B. The Q1-2026 spike to $52.6B was driven by the working-capital outflow plus a ~$3B non-cash variable shipping-lease revaluation, not by deterioration in financial debt. The financial balance sheet is genuinely strong (solid investment grade), stronger than the headline gearing implies.

Balance sheet (Dec 31, 2025). Cash $30.2B; total equity $175.3B (down from $180.2B as buybacks exceeded retained earnings); decommissioning and other provisions $27.3B (a large, long-dated, unfunded obligation typical of a major); pension a net asset of ~$5.1B (down from ~$10.0B on a −$4.2B OCI remeasurement — not a near-term cash concern). Liquidity is ample.

Verdict (Financial Quality): Economics are cyclical, not improving-with-scale — but the cash generation and balance-sheet quality are high and the per-share trajectory is excellent. ROACE swings with the commodity (no operating-leverage moat), Adjusted Earnings flatters the picture and should be discounted in favor of IFRS/FCF, and the trading book makes quarterly figures noisy. But through-cycle FCF is robust, leverage (ex-leases) is low, and the share count is falling fast. This is a financially well-run cyclical, not a compounding machine.


7. Capital Allocation

This is Shell’s strongest dimension and the engine of the re-rating. Under CEO Wael Sawan (since January 2023) the company executed a credible “value over volume” reset, formalized at the Capital Markets Days of June 2023 and March 2025.

The distribution framework. Distributions were raised from 30–40% to 40–50% of CFFO through the cycle (CMD March 2025), prioritizing buybacks while maintaining a progressive dividend (+~4%/yr); capex was cut and disciplined to $20–22B/yr (from $22–25B); and the structural cost-reduction target was raised to $5–7B cumulative by 2028 (already $5.1B achieved by end-2025). The capstone financial objective is >10% normalized FCF-per-share CAGR to 2030.

The numbers. FY2025 distributions totaled $22.4B ($8.5B dividends + $13.9B buybacks ≈ 52% of CFFO); cumulative 2023–25 distributions were ~$67.9B. Shell repurchased ~396M ordinary shares in 2025 (all for cancellation); the cumulative buyback over FY2022–25 was ~$60–65B, retiring ~12.5% of the share count in two years (weighted-average basic shares 6,733.5M → 5,890.8M). Management has stated buybacks were executed at an estimated ~20%+ IRR at the prices paid and targets retiring on the order of ~40% of shares over a 5–6-year horizon. This per-share machine is the cleanest, most reliable part of the thesis and the principal mechanism behind the >10% FCF/share target — it works even on flat Adjusted Earnings.

Two important moderating signals the bull case understates:

  1. Q1-2026: the buyback was trimmed from $3.5B to $3.0B/quarter (while the dividend was raised +5%), framed as “rebalancing, not rebasing” — diverting cash to the balance sheet for countercyclical future buybacks. The 40–50% policy is “sacrosanct,” but it is a range Shell flexes to the low end when it wants to conserve cash. After 17 consecutive quarters of ≥$3B, this is a real (if modest) deceleration.

  2. ARC Resources is ~75% equity-funded, which issues shares and partially reverses the share-count shrinkage that drove the re-rating. The Marathon-approved “shrinking the count into a depleting asset base” framing was accurate for 2022–25, but FY2026 marks a deliberate pivot toward funded growth — a defensible use of an expensive equity currency, but a change in posture.

M&A discipline. The ARC Resources acquisition (announced 27-Apr-2026; ~$22B incl. assumed net debt / ~$14B equity; C$32.80/share = 0.40247 Shell shares + C$8.20 cash; ~27% premium to last close, ~20% to 30-day VWAP) is FCF/share-accretive from 2027, carries ~$250M/yr of synergies, fills LNG Canada feedgas (Montney/Groundbirch), and lifts the production CAGR-to-2030 from ~1% to ~4%. The price is full but the strategic logic (feedgas integration, reserve-life extension) is coherent. Pavilion Energy (LNG) closed March 2025. Divestments have been disciplined and portfolio-rationalizing: SPDC Nigeria onshore (~$2.4B, closed 2025), the Singapore Energy & Chemicals Park, a Canadian oil-sands swap (10% mining interest for +10% Scotford upgrader + Quest CCS), and the cancellation of the Rotterdam HEFA biofuels plant (~$600M write-down).

Capital-cycle read (Marathon). Shell is doing what Marathon’s framework prescribes for a mature, depleting, low-pricing-power industry: restraining capex, returning capital aggressively, shrinking the share count, and high-grading the portfolio rather than chasing volume — the disciplined-incumbent playbook that creates value precisely because the rest of the industry’s capital is being rationalized. The one tension is the negative organic reserve replacement: returning ~50% of CFFO while reserves deplete and RRR runs negative means the upstream is partly being harvested, with ARC plugging the gap. That is a legitimate strategy for a value-over-volume major, but it must be named: Shell is, in part, liquidating a depleting asset base and returning the proceeds.

Verdict (Capital Allocation): Intelligently and shareholder-friendly allocated — among the best in the sector — but the per-share-shrink story is moderating in 2026 (buyback trim + ARC equity issuance + rising net debt). The discipline is real and is the legitimate reason for the re-rating; investors should simply not extrapolate the 2022–25 pace of share-count reduction uncritically into the future.


8. Changes and Headwinds — Last Two Years

Strategic reset (the re-rating engine). The Sawan “course correction” (CMD June 2023) and the raised financial bar (CMD March 2025) — capex cut, costs out, distributions up, per-share focus — are the central change of the period and the reason the stock re-rated. Strengthens the thesis on execution; the question is only how much is already priced.

Renewables pullback. Shell exited the supply of energy to European homes (uncompetitive), pivoted power toward commercial/select markets, scaled back hydrogen, and cancelled the Rotterdam HEFA biofuels plant. Improves near-term returns optics; raises long-run terminal/transition risk (Shell is leaning harder into hydrocarbons for longer).

Climate-target retreat. In its March 2024 Energy Transition Strategy, Shell dropped its 2035 net-carbon-intensity target and weakened the 2030 target (from 20% to 15–20%). This is financially rational given the renewables economics, but it is a governance/ESG-friction point and a reputational risk in certain jurisdictions.

Milieudefensie litigation — Shell won. The Hague Court of Appeal overturned (12-Nov-2024) the 2021 lower-court order requiring Shell to cut emissions 45% by 2030 — no court-imposed numeric target stands, though a general duty of care was affirmed. Removes a material legal overhang.

BP takeover speculation. The WSJ reported early-stage talks in June 2025; Shell issued a Rule 2.8 statement (26-Jun-2025) declaring “no intention of making an offer,” legally barring a bid for six months (now expired). Signals Shell’s strategic preference for organic discipline over transformational M&A — and management’s read that BP was not a compelling deal.

LNG Canada startup (2025). First export cargoes from Trains 1&2 — a multi-decade strategic asset coming online. Strengthens the LNG thesis.

Executive pay ratchet (a real watch-item). The May-2026 binding Remuneration Policy vote proposes the first policy-maximum increase since 2013 (CEO target PSA 300%→450% of salary, max 600%→900%), justified by a newly-reset “global peer group” spanning autos/pharma/tech/industrials — a classic ratchet-via-peer-reset, likely to draw investor pushback (see governance, below).

Verdict (Changes): On net, the changes strengthen the thesis — the strategic reset, the litigation win, and LNG Canada outweigh the renewables/climate-target retreat (largely a returns-positive realism) and the pay ratchet (a governance irritant, not a thesis-breaker). The genuine new headwinds are external and cyclical: the LNG supply wave, negative reserve replacement, and the eventual normalization of war-premium oil.


9. Risk Analysis

Risk Likelihood Impact Evidence / basis
Commodity-price decline (oil/gas) High High Pure price-taker; AE fell 34% 2023→25 on prices. ~$89–95 Brent is a Hormuz war premium reverting toward ~$60–70; FY2026 optic flatters normalized earnings.
LNG/trading-margin compression Med High 2025–2030 global LNG supply wave (Qatar, US Gulf) threatens the optimization spreads flattering Integrated Gas (Shell’s largest, least-recurring layer, $8.0B AE).
Multiple de-rating (P/B reversion) Med High P/B 1.42× = 97.9th pctile of own 10-yr history at trough 9.4% ROACE; principal downside is a multiple unwind toward the historical sub-1.2× Europe discount.
Negative reserve replacement / depletion Med Med FY2025 organic RRR ~−40% (3-yr avg ~55%); ~8-yr reserve life; upstream partly harvested, leans on ARC to stand still.
Buyback deceleration Med Med Q1-2026 trim ($3.5B→$3.0B/qtr) + ~75% equity-funded ARC partly reverse the share-shrink that drove the re-rating.
Chemicals trough persists Med Low C&P AE −71% over two years; global petrochemical oversupply; option value on recovery, but a persistent drag.
Energy-transition / demand-terminal risk Med Med Long-dated oil-demand uncertainty; Shell leaning into hydrocarbons longer after renewables pullback — magnifies terminal-value sensitivity.
Geopolitical / operational (assets) Med Med Diversified global footprint (Nigeria divested, Gulf of Mexico, Middle East, LNG Canada); single-asset risk lower than peers but real.
Regulatory / windfall tax / carbon Med Med European windfall-tax precedent; carbon pricing; climate-target retreat invites litigation/ESG friction in some jurisdictions.
Governance — pay ratchet / FPI structure Low Low May-2026 ~50% PSA quantum hike; FPI status means no Form 4 insider transparency, lighter US disclosure (20-F annual cadence).
FX (USD reporting / GBP dividend) Low Low Reports in USD; dividend declared in USD then converted; modest translation noise.
Catastrophic loss (spill/disaster) Low High Tail risk inherent to upstream/offshore; mitigated by scale, insurance, and a diversified asset base; low probability, severe if realized.

Overall risk read: The dominant risks are cyclical and valuation-driven, not solvency or franchise-destruction risks. The balance sheet (net debt ex-leases ~$16.8B) and the ~9% shareholder yield provide a genuine downside cushion; the principal way to lose money here is a multiple de-rating (P/B reverting to the Europe discount) compounded by an oil-price reversion — i.e., paying a near-record book multiple at trough returns and watching both the multiple and the earnings fall together.


10. Valuation Discussion (Embedded Expectations)

No price target and no recommendation. The following is embedded-expectations and scenario analysis only.

Cross-sectional comps (public market data, June 2026; reconciled where material):

Ticker Price Mkt cap ($B) Trailing P/E Fwd P/E EV/EBITDA P/S Div yield Cohort
SHEL 85.66 237 ~13.6 ~9.1 6.0 0.89 ~3.4% Euro major
TTE 88.02 196 13.1 8.7 6.1 1.06 4.79% Euro major
BP 42.78 110 34.5 10.4 14.6 0.57 4.67% Euro major (turnaround)
XOM 147.01 609 24.7 13.8 11.7 1.87 2.80% US major
CVX 187.22 373 32.6 14.9 11.0 2.01 3.80% US major
COP 116.98 147 ~20 12.7 6.8 2.40 2.83% US large-cap E&P

The cross-sectional read: Shell trades at a ~45% EV/EBITDA discount to XOM/CVX (6.0× vs ~11–12×) and a ~34% forward-P/E discount, sitting squarely with TotalEnergies (the European-major cohort). The persistent “Europe/IOC discount” — EU domicile and windfall-tax history, trading-and-renewables opacity, a lower-quality reserve base than Guyana/Permian — is intact even after Shell’s re-rate. On a cross-section, Shell is the cheap supermajor.

The central tension — own-history percentiles (own-history valuation index, June 2026):

Metric Value (per ADR) Own-10yr percentile
P/E 14.5× (TTM EPS $5.92) 66.3rd
P/B 1.42× (BV $60.14/ADR) 97.9th
P/S 0.97× (sales $88.55) 98.0th
Composite 87.4th

This is the single most important valuation fact, and it is not the ExxonMobil/Chevron setup (both rich on every axis, ~95th+ composite). Shell is middling on earnings (66th P/E) but at all-time-high P/B and P/S (98th). The interpretation: this is a balance-sheet/revenue re-rating, not an earnings-multiple one. Shell’s P/B spent most of the last decade below 1.0× — a chronic Europe/conglomerate discount — and has re-rated to 1.42×, moving toward (not to) US-major parity (CVX ~1.7×, XOM ~2.5×). The 98th-percentile P/B is the market saying the discount-narrowing has largely already happened; the 66th-percentile P/E says earnings are at a cyclical trough and the market is sensibly not paying up on trough earnings. The bull “re-rating runway to US parity remains” and the bear “the re-rate is done, P/B has no room” are arguing over the same data point — and the honest read is that the easy multiple expansion is behind us.

Embedded-expectations decomposition. At $85.66 (EV ~$295B), Shell trades at ~6.0× FY2025 EV/EBITDA and 9.4% trough ROACE. To support ~$295B of EV at a defensible ~5× mid-cycle EV/EBITDA requires roughly $55–60B of normalized EBITDA — i.e., management’s 2030 plan (ROACE >10% across all segments at a normalized $70 Brent, FCF/share >10%/yr, LNG +4–5% CAGR, production CAGR to ~4% post-ARC) substantially delivered. Crucially, the current price does not appear to extrapolate the Hormuz spike — the 66th-percentile P/E confirms the market is not capitalizing ~$90 oil — but it does capitalize the plan plus the buyback compounding. The margin of safety on the operating plan is moderate; the stretch is paying a near-record book multiple at a record-low return.

Sum-of-the-parts. A SOTP that pays a premium infrastructure multiple for the scarce #1 LNG franchise, a ~10–12× retail multiple for the stable Marketing annuity, troughs Chemicals on option value, and discounts Renewables as a capital sink lands broadly in line with the current ~$295B EV — Shell is not obviously cheap on parts. The genuine SOTP arguments are (a) Marketing is under-credited as a stable annuity and (b) the LNG franchise is scarce; both are partly offset by the low quality of the embedded LNG-trading earnings and the negative organic reserve replacement in Upstream.

Scenarios — ~2.83B ADSs, ~3-year horizon (war premium normalized out):

Scenario Norm. Brent Norm. AE ($B) Adj EPS/ADR Lens / multiple logic Principal driver
Bear ~$60 ~13–16 ~$4.5–5.7 P/B reverts toward ~1.0–1.2× Europe discount Oil reversion + LNG-margin squeeze + buyback throttled to defend the band + de-rate. A multiple unwind.
Base ~$70 ~20–25 ~$7–9 ~10–11× P/E; EV/EBITDA ~5× as E recovers; P/B ~1.4× holds ROACE clears >10%; per-share compounding does the work. Roughly fair near the current price.
Bull ~$85+ ~28–34 ~$10–12 Re-rate continues toward CVX P/B (~1.6–1.7×); EV/EBITDA holds LNG super-cycle margins hold + ~4% production growth + share shrink + further discount-closing.

The skew is more symmetric than ExxonMobil’s precisely because Shell is not at a peak earnings multiple — the “peak multiple at trough returns” trap is only half-present (a peak P/B, not a peak P/E), and the ~9% shareholder yield pays you to wait. The asymmetry that is present sits on the P/B axis: the 98th-percentile book multiple is the vulnerable variable, and a reversion to the historical sub-1.2× Europe discount is the principal downside — a multiple risk, not an earnings risk.

Verdict (Valuation): The market is underwriting successful delivery of the 2030 plan on normalized ~$70 oil, plus continued per-share compounding — and is sensibly not capitalizing the war premium. It is correctly pricing Shell’s cash-flow cheapness relative to the US majors and the genuineness of the discipline; it may be over-pricing the durability of LNG-trading margins and under-appreciating that the easy P/B re-rating is done. The cash-flow yield is the value; a second leg of multiple expansion is not the base case.


11. Variant Perception

Consensus (bullish; analyst rating ~4.4/5; consensus implied target ~$100/ADR; short interest only ~1.8% of float). “The Sawan turnaround is working — radical capital discipline (capex cut to $20–22B), 40–50% of CFFO returned, the biggest buyback in the sector retiring ~40% of shares over time, the #1 global LNG position riding a demand super-cycle, and a P/B re-rating closing the historical gap to the US majors.” The bear is not consensus — this is a crowded, lightly-hedged long.

Strongest bull case. (1) LNG demand super-cycle (Shell projects +~60% to 2040, AI/Asia-driven) and Shell owns the #1 global trading/shipping franchise to monetize it. (2) Per-share compounding — buyback retiring ~40% of shares + ~4% dividend growth ⇒ >10% FCF/share even on flat oil. (3) Continued P/B re-rate toward CVX/XOM parity as the discount narrows and ROACE clears >10%. (4) Marketing is a stable ~$4B annuity the market under-credits in a SOTP. (5) ARC lifts production CAGR to ~4%, adding genuine volume atop the per-share story.

Strongest bear case. (1) Commodity price-taker at trough ROACE (9.4%) paying a 98th-percentile P/B (1.42×) — near-record book value for record-low returns. (2) The re-rating is done — P/B has little room without proof ROACE is structurally >10% (not just at war prices). (3) The 2025–2030 LNG supply wave compresses the trading/optimization margins flattering Integrated Gas, Shell’s largest and least-recurring layer. (4) Negative organic reserve replacement (~−40% FY2025) — the upstream is harvesting reserves and leaning on M&A. (5) The ~$89–95 Brent is a Hormuz war premium reverting toward the EIA low-$60s/$70s strip — normalized earnings sit below the optic. (6) The buyback was already trimmed in Q1-2026 — capacity is being conserved, not expanded.

The 3–5 load-bearing assumptions and their falsifiers:

  1. ROACE structurally clears >10% at $70 Brent (not just at war prices) — falsified by ROACE stuck ~9–10% once oil normalizes.
  2. The P/B re-rating holds at ~1.4× and does not revert to the historical sub-1.0–1.2× Europe discount — falsified by P/B compressing back toward 1.0× on any disappointment.
  3. LNG/IG margins survive the 2025–2030 supply wavefalsified by Integrated Gas AE falling on compressed trading spreads despite higher volumes.
  4. The buyback is sustained at 40–50% of CFFO through a downturnfalsified by a cut below the band to defend the balance sheet at low oil.
  5. Normalized Brent is $70+, not $60sfalsified by a post-Hormuz reversion to the $50s–60s.

Variant conclusion. The quality genuinely improved under Sawan — the discipline is real, the per-share machine works, and the cross-sectional discount to the US majors is wide. But the discount-closing trade is largely behind us: the market already pays a 98th-percentile P/B and P/S for a price-taker at trough returns on war-premium oil, with negative organic reserve replacement and an LNG supply wave bearing down on its largest segment. The variant edge is not “Shell is broken” — it is “the easy multiple expansion has happened; from here you are underwriting structural >10% ROACE and durable LNG margins to justify the re-rated book multiple, while the cheap-looking forward P/E is partly an artifact of war-premium oil that will normalize down. You are paid a ~9% yield to wait, and the cash-flow cheapness versus the US majors is the real edge — but it is a deep-value cyclical, not a quality compounder, and it should be sized and entered as one.”


12. Fact vs. Interpretation

# Statement Type Basis / caveat
1 FY2025 Adjusted Earnings $18.5B, down from $39.9B (2022); ROACE 9.4% (vs 12.8% 2023) Fact FY2025 20-F
2 Shell is the #1 listed LNG supplier (~17% of global trade; ~44 Mtpa equity; record 72.9 Mt sold 2025) Fact 20-F; corroborated by third-party LNG trade data
3 P/B 1.42× = 97.9th pctile, P/S 98.0th, P/E 66.3rd of own 10-yr history Fact own-history valuation index, June 2026 (own-history percentiles only; not cross-sectional)
4 The ~$89–95 Brent is a transient Strait-of-Hormuz war premium, not a structural price Interpretation April-2026 monthly avg $117 (highest since 2008); EIA strip reverts lower — but timing/level uncertain
5 Shell has no franchise moat; it is a commodity price-taker with a cost advantage + LNG/trading edge Interpretation Greenwald framework; the 34% earnings decline on an unchanged asset base is the disconfirming test
6 The easy P/B re-rating (discount-closing) is largely complete Interpretation 98th-pctile P/B at trough ROACE; bull/bear disagree on remaining runway
7 FY2025 organic reserve replacement was negative (~−40%); reserve life ~8 yrs Fact 20-F reserves note; the −40% is the 2025 organic figure (3-yr avg ~55%)
8 The >10% FCF/share CAGR target is achievable largely via buyback even on flat AE Interpretation Mechanical from ~3–4%/yr share shrink + cost-out; assumes buyback sustained
9 Net debt $45.7B overstates leverage; net debt ex-leases ~$16.8B Fact 20-F: ~$28.9B of net debt is lease liabilities
10 ARC Resources (~$22B, ~75% equity) lifts production CAGR to ~4% but partly reverses the share shrink Fact/Interp. Announced 27-Apr-2026; accretion from 2027 is management guidance (a hypothesis)
11 Adjusted Earnings systematically flatters IFRS net income via recurring impairments in “identified items” Interpretation −$8.2B/−$7.4B identified items 2023/24; FY25 gap closed only via a ~$1.95B disposal gain
12 The May-2026 executive-pay policy proposes the first quantum hike since 2013 (PSA max 600%→900%) Fact 20-F / Remuneration Policy; investor-vote outcome post-dates this report

13. Open Questions

  1. Does ROACE clear >10% at a normalized ~$70 Brent, or is the >10%-per-segment target only achievable at war-premium prices? (The single most important unknown.)
  2. What is the durable, mid-cycle level of LNG-trading/optimization margin once the 2025–2030 supply wave lands — and how much of Integrated Gas’s $8.0B is recurring vs volatility-driven? (Shell does not disclose trading P&L granularly.)
  3. Precise pro-forma share-count dilution from ARC (~75% equity-funded) versus the ongoing buyback — i.e., the net per-ADR effect.
  4. Will the buyback return to ≥$3.5B/quarter, or is the Q1-2026 trim the start of a structurally lower pace?
  5. Where does normalized Brent settle post-Hormuz — $70+ (base) or $50s–60s (bear)?
  6. Does the May-2026 binding remuneration vote pass cleanly, and does the pay ratchet signal a governance drift?
  7. Can organic reserve replacement recover toward ~100%, or will Shell remain structurally reliant on M&A to hold production?

14. What Must Be True

For the bull case to work:

  • Normalized Brent settles ~$70+ and ROACE clears >10% across segments on that normalized deck (not war prices). Falsification: ROACE stuck ~9–10% once oil normalizes toward the strip.
  • LNG-trading and optimization margins hold through the 2025–2030 supply wave, so Integrated Gas AE grows with volume rather than shrinking on compressed spreads. Falsification: Integrated Gas AE falls despite higher LNG sales volumes.
  • The buyback is sustained at 40–50% of CFFO and the share count keeps shrinking ~3–4%/yr, delivering the >10% FCF/share CAGR. Falsification: buyback cut below the band; share count flat or rising after ARC.
  • The 1.42× P/B holds or re-rates further toward US-major parity. Falsification: P/B reverts toward the historical sub-1.2× Europe discount.

For the bear case to work:

  • Brent reverts to the $50s–60s post-Hormuz and stays there, dragging AE toward ~$13–16B. Falsification: structural $70+ oil on durable supply discipline.
  • The P/B de-rates toward the historical Europe discount as the market concludes trough returns don’t justify a near-record book multiple. Falsification: ROACE proof >10% at normalized oil sustains the multiple.
  • The LNG supply wave compresses trading margins and Integrated Gas earnings fall. Falsification: LNG demand outpaces supply and spreads hold.
  • The upstream keeps under-replacing reserves and the per-share machine decelerates (buyback trim + ARC dilution), undercutting the FCF/share story. Falsification: RRR recovers toward ~100% and the buyback returns to ≥$3.5B/qtr.

15. Source Appendix

See Appendix B for the full, dated source list. Primary sources: Shell plc Form 20-F FY2025 (filed 2026-03-12), FY2024 (2025-03-25) and FY2023 (2024-03-14); the 6-K corpus (2024–2026, incl. Q1-2026 and Q4-2025 results); Shell Capital Markets Day (2025-03-25), Q1-2026 (2026-05-07), Q4-2025 (2026-02-05) earnings calls and the ARC Resources M&A call (2026-04-28); UK RNS/PDMR notifications; own-history valuation index and public market data (June 2026); EIA and third-party LNG-trade data; cross-sector comparison with US and European integrated-oil peers (XOM, CVX, COP, BP, TTE).


APPENDIX A — Standard Diligence Questionnaire

Shell plc (NYSE: SHEL) | Report date 2026-06-13 | ADR ~$85.66 (1 ADR = 2 ordinary shares)

Supplemental to the memo; F/I/A = Fact / Interpretation / Assumption.

General

What thoughtful questions have other investors asked about this company? The recurring institutional questions: (1) How much of the Sawan re-rating is left — has the discount to ExxonMobil/Chevron closed as far as it can? (2) How recurring are the LNG-trading earnings that drive Integrated Gas, and how exposed are they to the 2025–2030 supply wave? (3) Is the 40–50%-of-CFFO buyback sustainable through a down-cycle, or was the Q1-2026 trim a signal? (4) Why is organic reserve replacement negative, and does that force more M&A? (5) Does ROACE genuinely clear >10% at a normalized (not war-premium) oil price? (6) Is the renewables/energy-transition pullback a returns-positive realism or a terminal-value risk? (Interpretation, synthesized from the transcript Q&A and sell-side framing.)

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? A low. Adjusted Earnings fell from a $39.9B record (2022) to $18.5B (2025), and ROACE from 15.8% to 9.4% — a cyclical trough on lower oil/LNG prices, weaker trading margins and a chemicals down-cycle. (Fact, 20-F.) FY2026 will be temporarily flattered by the Hormuz war premium, but that is not a structural high.

Driven by the external environment or internal actions? Overwhelmingly external (commodity prices). Internal actions (cost-out, capex discipline, buybacks) have improved through-cycle earnings power and per-share value but cannot offset the price cycle. (Interpretation.)

How stable are revenues? Not stable — revenue swung $381B (2022) → $267B (2025). The only stable layer is Marketing (~$4B AE, rising counter-cyclically) and the contracted/infrastructure portion of LNG. (Fact/Interp.)

Outlook for products/services? LNG demand projected +~60% to 2040 (company outlook); oil demand long-dated and uncertain; chemicals trough with eventual cyclical recovery; Marketing durable. (F/A — the LNG growth figure is management’s outlook, a hypothesis.)

How big will this market be — growing, shrinking, domestic or international? Global and international. LNG growing; oil plateauing-to-slowly-declining over a multi-decade horizon; refining/chemicals mature. (Interpretation.)

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Less on the supply side near-term (consolidation + capital discipline rationalizing upstream capital — favorable Marathon capital-cycle setup), but LNG is attracting heavy new capacity (more competitive in that niche later this decade). (Interpretation.)

How profitable is the business (ROIC, ROE)? ROACE 9.4% (2025, trough); ROE ~10.7%. Cyclical, mid-single-to-low-double-digit — not moat-like through-cycle. (Fact.)

How profitable is the industry — competitors, barriers to entry? A consolidated oligopoly of supermajors + NOCs + independents; high capital and technical barriers to entry, but no pricing power (commodity). Returns set by price, not structure. (Interpretation.)

Can the business be easily understood? Mostly — five clear segments — except the trading/optimization book, which is large, opaque and deliberately undisclosed at the P&L level. (Interpretation.)

Can it be undermined by foreign low-cost labor? No — capital-, technology- and resource-intensive, not labor-arbitrage-exposed. (Fact/Interp.)

Do brands matter? Only in Marketing (Shell-branded retail fuel, #1 global lubricants brand) and to a degree in B2B/aviation. Upstream/LNG/chemicals are commodities. (Interpretation.)

Nature of competition / customers’ switching costs? Price competition in commodities; modest switching costs in lubricants/retail (brand, convenience network) and in long-term LNG offtake contracts (counterparty relationships, infrastructure). (Interpretation.)

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The trading franchise’s intangible/optionality value and the Marketing brand are not capitalized; the LNG portfolio’s scarcity value is understated at book. (Interpretation.)

Off-balance-sheet liabilities? Decommissioning/abandonment obligations are on balance sheet ($27.3B provisions) but are long-dated and unfunded; JV and contractual purchase commitments exist (normal for a major). Pension is a net asset (~$5.1B). (Fact, 20-F.)

How conservative is the accounting? IFRS; the headline metric (“Adjusted Earnings”) flatters IFRS net income by excluding recurring impairments via “identified items” — treat with skepticism and weight IFRS/FCF. Net-debt optics are conservative (include ~$28.9B leases; ex-leases ~$16.8B). (Interpretation.)

How CapEx-hungry is the business? Very — ~$20–22B/yr of cash capex, and it must reinvest perpetually against a depleting reserve base (negative organic RRR in 2025). This is a structural feature of the industry. (Fact.)

Capital Allocation & Management

How much FCF, and how is it used? FCF $26.1B (2025); used for a progressive dividend (~$8.5B) and buybacks (~$13.9B), totaling ~$22.4B (≈52% of CFFO). Policy: 40–50% of CFFO through the cycle, buyback-prioritized. (Fact, 20-F.)

Philosophy? “Value over volume” — capex discipline, structural cost-out ($5.1B since 2022), per-share-value compounding, portfolio high-grading. Among the most disciplined in the sector. (Interpretation.)

Significant acquisitions recently? ARC Resources (~$22B, ~75% equity, announced Apr-2026 — Montney gas, LNG Canada feedgas, accretive 2027); Pavilion Energy (LNG, closed Mar-2025). Plus disciplined divestments (SPDC Nigeria onshore, Singapore chemicals park, Rotterdam HEFA cancelled). (Fact.)

Buying back shares? Yes, aggressively — ~$60–65B FY2022–25, share count −12.5% in two years; targeting ~40% reduction over 5–6 years. But trimmed to $3.0B/quarter in Q1-2026 (from $3.5B). (Fact.)

Issuing large amounts of new shares to insiders? No material insider issuance; executive pay is share-award-based (PSA/bonus) but modest relative to share count. ARC will issue equity to sellers, not insiders. (Fact.)

Compensation policy? Returns-aware metrics: relative TSR, relative capital-allocation/ROACE proxy, absolute organic FCF, energy-transition, and (2026) FCF/share growth — benchmarked vs bp/Chevron/ExxonMobil/TotalEnergies with a stretching schedule (4th–5th place = 0% vesting). CEO Sawan FY2025 single-figure pay ~£13.8M (~$18M), up ~60% on share vesting. Watch-item: May-2026 binding policy vote proposes the first quantum hike since 2013 (PSA max 600%→900%) via a reset global peer group — a classic ratchet. (Fact.)

Motivations of management? Largely aligned via share-price-linked pay and relative-performance hurdles; insider ownership is low (~0.1%) and there are no discretionary open-market insider buys (Shell files no Form 4s; UK PDMR notifications show only routine vestings) — no bullish insider tell. (Fact/Interp.)

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? An ADR (NYSE: SHEL); each ADR = 2 ordinary shares. Ordinary shares also trade on the LSE (SHEL) and Euronext Amsterdam. Not an MLP; no K-1 (1099 dividend reporting; US investors should note UK/Dutch withholding considerations — historically Shell’s structure avoided Dutch dividend withholding on the primary line). (Fact.)

Dividend policy? Progressive, +~4–5%/yr; ~$2.89/ADR trailing (~3.4% yield; ~3.6% forward after the Q1-2026 +5% raise). Combined with buybacks, total shareholder yield ~9%. (Fact.)

How profitable is the business? Cyclically — ROACE 9.4% (trough), net margin ~7%. Through-cycle mid-teens at peak. (Fact.)

Is net income diverging from cash from operations? CFFO ($42.9B) far exceeds IFRS net income ($18.1B), normal given ~$25B DD&A. CFFO is volatile quarter-to-quarter via trading working-capital swings (e.g., ~$11B Q1-2026 outflow expected to reverse). (Fact.)

Risks & Downside

What would cause the stock to decline? A crude/LNG price reversion (Hormuz de-escalation toward $60s oil); LNG-trading-margin compression from the supply wave; a P/B de-rating toward the historical Europe discount; a buyback cut; persistent chemicals trough; an energy-transition demand shock. (Interpretation.)

Risk of catastrophic loss? Low-probability/high-severity tail risk inherent to offshore/upstream (a major spill or disaster), mitigated by scale, insurance and diversification. (Interpretation.)

Chance of a total loss? Negligible — strong investment-grade balance sheet (net debt ex-leases ~$16.8B), ~$30B cash, ~$43B CFFO, a 100±year diversified franchise. This is a valuation/cyclical risk, not a solvency risk. (Interpretation.)

Recent News & Events

(Built from company filings, earnings-call transcripts and UK regulatory news.)

Has the business environment changed recently? Yes — the Strait-of-Hormuz disruption pushed Brent to ~$117 (April-2026 monthly avg) before easing toward ~$89–95 in June; a transient war premium, not a structural shift. (Fact.)

Significant acquisitions? ARC Resources (~$22B, Apr-2026); Pavilion Energy (Mar-2025). (Fact.)

Change in accounting policies? Segments re-presented effective 1-Jan-2025 (so per-segment AE is comparable FY2023–25 only). (Fact.)

Recent changes — markets, facilities, management? LNG Canada first cargoes (2025); SPDC Nigeria onshore exit (2025); Rotterdam HEFA cancellation (~$600M write-down); 2024 climate-target retreat (dropped 2035 carbon-intensity target); won the Milieudefensie appeal (Nov-2024); the denied BP takeover speculation (Jun-2025); CEO Wael Sawan (since Jan-2023), CFO Sinead Gorman. (Fact.)


APPENDIX B — Source Appendix

Shell plc (NYSE: SHEL) | Report date 2026-06-13

Sources prioritized primary-first. All figures reconciled to the Form 20-F where possible; third-party/aggregated market data is convenience data and flagged as such. As a foreign private issuer, Shell files Form 20-F (annual, IFRS, USD) and Form 6-K (interim) — not 10-K/10-Q — and files no Form 3/4/5 (director/PDMR dealings are disclosed under UK MAR rules via RNS).

Primary — SEC filings (EDGAR, CIK 0001306965)

  1. Form 20-F, FY2025 — filed 2026-03-12 (shel-20251231.htm). Financial statements, segment Note 7, reserves note, Item 6 (directors/compensation/Remuneration Report), risk factors. Primary source for all FY2025 financials, segment Adjusted Earnings, ROACE, net debt, reserves, production, capital allocation, executive pay. https://www.sec.gov/Archives/edgar/data/1306965/000162828026017024/shel-20251231.htm
  2. Form 20-F, FY2024 — filed 2025-03-25 (shel-20241231.htm). FY2024/FY2023 comparatives.
  3. Form 20-F, FY2023 — filed 2024-03-14 (shel-20231231.htm). FY2021/FY2022 comparatives; restated FY2023 ROACE.
  4. Form 6-K — Q1-2026 results — filed 2026-05-07 (shellq120266-k.htm). Q1-2026 earnings, buyback trim to $3.0B/qtr, +5% dividend, working-capital/net-debt commentary.
  5. Form 6-K — Q4-2025 results — filed 2026-02-05 (shellq420256-k.htm). FY2025 reserves/RRR, full-year distributions.
  6. 6-K corpus 2024–2026 — buyback “transaction in own shares” notices, debt programme filings, divestment/M&A announcements.

Primary — company calls & investor events (earnings-call transcripts)

  1. Shell Capital Markets Day — 2025-03-25 (~164k chars). The 2030 financial framework: distributions 40–50% of CFFO, capex $20–22B/yr, $5–7B cost-out, >10% FCF/share CAGR, LNG +4–5% CAGR, ROACE >10%/segment at $70 Brent.
  2. Q1-2026 earnings call — 2026-05-07. Buyback rebalancing (“not rebasing”), Hormuz/Oman commentary, ARC progress.
  3. Q4-2025 earnings call — 2026-02-05. FY2025 results, RRR, cost-out progress.
  4. ARC Resources M&A call — 2026-04-28 (~50k chars). Deal terms (~$22B, ~75% equity, ~$250M synergies, accretive 2027), Montney/LNG Canada feedgas rationale.
  5. Q3-2025 / Q2-2025 earnings calls — 2025-10-30 / 2025-07-31. Segment trajectory, trading-margin commentary.

Primary — UK regulatory

  1. UK RNS / PDMR notifications (2025) — director/PDMR share dealings: routine LTIP/PSA vestings, conditional awards, dividend reinvestment; no discretionary open-market buys.
  2. Rule 2.8 statement re BP — 2026-06-26 (sic 2025-06-26): “no intention to make an offer” (6-month standstill under the UK Takeover Code).

Secondary — market & industry data

  1. Own-history valuation index (June 2026) — Shell’s valuation percentiles versus its own ~10-year history: P/E 66.3rd, P/B 97.9th, P/S 98.0th, composite 87.4th. Compared only against Shell’s own history, not cross-sectionally.
  2. Public market data (June 2026) — price, market cap, EV, multiples, peer comps (XOM, CVX, BP, TTE, COP). Reconciled to filings where material.
  3. EIA — Brent forward strip / oil-price outlook; Strait-of-Hormuz disruption context (April-2026 monthly avg Brent $117.29).
  4. Third-party LNG-trade data — global LNG trade ~407 Mt (2024); Shell ~17% trading share (#1).
  5. The Hague Court of Appeal ruling, Milieudefensie v. Shell — 2024-11-12 (Shell prevailed; 2021 numeric-cut order overturned).